Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 6/20 | 0.62 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.62 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.59 |
| ▸ | APLNR | P35414 | 1/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.54 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.54 |
| ▸ | F2 | P00734 | 4/20 | 0.54 |
| ▸ | ANPEP | P15144 | 1/20 | 0.54 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.54 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29973760 | 0.95 | AGTR2 (0.63) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| SCHEMBL9010599 | 0.95 | AGTR1 (0.62) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| SCHEMBL9010604 | 0.95 | AGTR1 (0.62) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| SCHEMBL29649735 | 0.95 | AGTR1 (0.62) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| Angiotensin Ii SCHEMBL9013957 | 0.95 | AGTR2 (0.69) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| Angiotensin Ii SCHEMBL22125774 | 0.95 | AGTR2 (0.69) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| Angiotensin Ii SCHEMBL29757879 | 0.95 | AGTR2 (0.69) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| Angiotensin Ii SCHEMBL9013950 | 0.95 | AGTR2 (0.69) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| SCHEMBL30445863 | 0.95 | AGTR2 (0.69) | AGTR1AGTR2C5AR1APLNRNTSR2 | |
| SCHEMBL29976758 | 0.95 | AGTR2 (0.65) | AGTR1AGTR2C5AR1APLNRNTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090251-A1 | METHODS FOR IMPROVING TREATMENT OUTCOMES IN PATIENTS UNDERGOING ULTRAFILTRATION | PROLETARIAT THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |